Stock Research for CARA

CARA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CARA Stock Chart & Research Data

The CARA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CARA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CARA Due diligence Resources & Stock Charts

The CARA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CARA Detailed Price Forecast - CNN Money CNN View CARA Detailed Summary - Google Finance
Yahoo View CARA Detailed Summary - Yahoo! Finance Zacks View CARA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CARA Trends & Analysis - Trade-Ideas Barrons View CARA Major Holders - Barrons
NASDAQ View CARA Call Transcripts - NASDAQ Seeking View CARA Breaking News & Analysis - Seeking Alpha
Spotlight View CARA Annual Report - CompanySpotlight.com OTC Report View CARA OTC Short Report - OTCShortReport.com
TradeKing View CARA Fundamentals - TradeKing Charts View CARA SEC Filings - Bar Chart
WSJ View Historical Prices for CARA - The WSJ Morningstar View Performance/Total Return for CARA - Morningstar
MarketWatch View the Analyst Estimates for CARA - MarketWatch CNBC View the Earnings History for CARA - CNBC
StockMarketWatch View the CARA Earnings - StockMarketWatch MacroAxis View CARA Buy or Sell Recommendations - MacroAxis
Bullish View the CARA Bullish Patterns - American Bulls Short Pains View CARA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CARA Stock Mentions - StockTwits PennyStocks View CARA Stock Mentions - PennyStockTweets
Twitter View CARA Stock Mentions - Twitter Invest Hub View CARA Investment Forum News - Investor Hub
Yahoo View CARA Stock Mentions - Yahoo! Message Board Seeking Alpha View CARA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CARA - SECform4.com Insider Cow View Insider Transactions for CARA - Insider Cow
CNBC View CARA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CARA - OTC Markets
Yahoo View Insider Transactions for CARA - Yahoo! Finance NASDAQ View Institutional Holdings for CARA - NASDAQ


Stock Charts

FinViz View CARA Stock Insight & Charts - FinViz.com StockCharts View CARA Investment Charts - StockCharts.com
BarChart View CARA Stock Overview & Charts - BarChart Trading View View CARA User Generated Charts - Trading View




Latest Financial News for CARA


Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark
Posted on Thursday May 25, 2023

You may think that with a price-to-sales (or "P/S") ratio of 4.4x Cara Therapeutics, Inc. ( NASDAQ:CARA ) is a stock to...


Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich… or Broke.
Posted on Thursday May 18, 2023

While the traditional approach to market success calls for patiently investing in reliable blue chips, those that want to see more immediate gains may consider small-cap stocks to buy. Here, the point is about accepting massive risk to hopefully realize massive rewards. At the same time, these lower-volume enterprises can be volatile, making this category inappropriate for the faint of heart. On the optimistic side of the equation, few other investment categories offer the upside reward potentia


Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus
Posted on Wednesday May 17, 2023

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England's National Institute for Health and Care Excellence (NICE) has recommended Kapruvia® for the treatment of moderate-to-severe CKD-associated pruritus in adult patients on haemodialysis. The decision follows authorisation from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) in April 2022.


Q1 2023 Cara Therapeutics Inc Earnings Call
Posted on Tuesday May 16, 2023

Q1 2023 Cara Therapeutics Inc Earnings Call


Stock Market & Investing Books

Enter a stock symbol to view the stock details.